Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer

ClinicalTrials.gov ID: NCT03778931

Public ClinicalTrials.gov record NCT03778931. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 4:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Elacestrant Monotherapy vs. Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer Following CDK4/6 Inhibitor Therapy: A Phase 3 Randomized, Open-label, Active-controlled, Multicenter Trial

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This Phase 3 clinical study compares the efficacy and safety of elacestrant to the standard of care (SoC) options of fulvestrant or an aromatase inhibitor (AI) in women and men with breast cancer whose disease has advanced on at least one endocrine therapy including a CDK4/6 inhibitor in combination with fulvestrant or an aromatase inhibitor (AI).

Study identification

NCT ID
NCT03778931
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Stemline Therapeutics, Inc.
Industry
Enrollment
478 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 10, 2019 (Actual)
Primary completion
Aug 24, 2021 (Actual)
Completion
Aug 22, 2024 (Actual)
Last update posted
Sep 15, 2025

2019 – 2024

United States locations

U.S. sites
104
U.S. states
35
U.S. cities
87
Facility City State ZIP Site status
The University of Arizona Cancer Center Tucson Arizona 85724 —
St Bernard's Cancer Care Jonesboro Arkansas 72401 —
St. Jude Heritage Healthcare Fullerton California 92835 —
Adventist Health Glendale Glendale California 91206 —
Moores Cancer Center at UC San Diego Health La Jolla California 92093 —
Keck Hospital of USC-Norris Healthcare (HC3), Investigational Drug Service (IDS) Los Angeles California 90033 —
Keck Medical Center of USC Los Angeles California 90033 —
USC IDS Pharmacy Los Angeles California 90033 —
UCLA Hematology/Oncology Los Angeles California 90095 —
UCLA West Medical Pharmacy 159 Los Angeles California 90095 —
TMPN Cancer Care Redondo Beach California 90277 —
UC Davis Medical Center, Investigational Drug Service Sacramento California 95817 —
UCSF Medical Center San Francisco California 94115 —
Ridley-Tree Cancer Center Santa Barbara California 93105 —
Anschutz Cancer Center Pavilion Aurora Colorado 80045 —
US Oncology - Rocky Mountain Cancer Centers - Midtown Denver Colorado 80218 —
Poudre Valley Health Care, Inc. d/b/a Poudre Valley Health System Fort Collins Colorado 80528 —
UCHealth Cancer Center Fort Collins Colorado 80528 —
Yale Cancer Center New Haven Connecticut 06511 —
MedStar Washington Hospital Center Washington D.C. District of Columbia 20010 —
Orlando Health Cancer Institute Orlando Florida 32806 —
Moffitt Cancer Center Tampa Florida 33612 —
Piedmont Cancer Institute, P.C. - Oncology Atlanta Georgia 30318 —
Suburban Hematology-Oncology Associates Lawrenceville Georgia 30046 —
Northwest Georgia Oncology Centers Marietta Georgia 30060 —
Chicago Association for Research and Education in Science Chicago Illinois 60141 —
Rush University Cancer Center Chicago Illinois 60612 —
Cancer Care Center of Decatur Decatur Illinois 62526 —
Joliet Oncology-Hematology Associates Joliet Illinois 60435 —
Presence Medical Group Hematology Oncology Skokie Illinois 60077 —
Simmons Cancer Institute Springfield Illinois 62702 —
Healthcare Research Network II Tinley Park Illinois 60487 —
Fort Wayne Medical Oncology And Hematology Fort Wayne Indiana 46815 —
Goshen Center for Cancer Care Goshen Indiana 46526 —
Hematology Oncology Of Indiana Indianapolis Indiana 46260 —
Cancer Resource Centre Munster Indiana 46321 —
University of Kansas Cancer Center Westwood Kansas 66205 —
Norton Cancer Institute Louisville Kentucky 40207 —
Pikeville Medical Center - Oncology/Hematology Pikeville Kentucky 41501 —
Ochsner Medical Center New Orleans Louisiana 70121 —
Highland Clinic Shreveport Louisiana 71105 —
New England Cancer Specialists Scarborough Maine 04074 —
The Gynecologic Oncology Center at Mercy Baltimore Maryland 21202 —
Weinberg Cancer Institute at Franklin Square Baltimore Maryland 21237 —
Maryland Oncology Hematology Frederick Maryland 21702 —
Boston Medical Center Boston Massachusetts 02111 —
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114 —
Mass General Cancer Center at Newton Wellesley - Oncology Boston Massachusetts 02462 —
Mass General North Shore Cancer Center - Oncology Danvers Massachusetts 01923 —
Karmanos Cancer Institute Detroit Michigan 48201 —
Minnesota Oncology Minneapolis Minnesota 55404 —
Mayo Clinic Rochester Minnesota 55905 —
Jackson Oncology Associates, PLLC. Jackson Mississippi 39202 —
Chub O'Reilly Cancer Center Springfield Missouri 65807 —
The Fred & Pamela Buffett Cancer Center Omaha Nebraska 68105 —
Precision Cancer Research Freehold New Jersey 07728 —
Saint Barnabas Medical Center - Cancer Center Livingston New Jersey 07039 —
The Steeplechase Cancer Center Somerville New Jersey 08876 —
New Mexico Oncology Hematology Consultants - Oncology Albuquerque New Mexico 87109 —
New Mexico Cancer Care Alliance Albuquerque New Mexico 87131 —
New York Oncology Hematology Albany New York 12206 —
Northern Westchester Hospital Cancer Center Mount Kisco New York 10549 —
New York University Clinical Cancer Center New York New York 10016 —
Stony Brook University Stony Brook New York 11794 —
Montefiore Medical Center The Bronx New York 10461 —
Oncology and Hematology of White Plains White Plains New York 10601 —
Carolina Institute For Clinical Research Fayetteville North Carolina 28304 —
US Oncology Network Cincinnati Ohio 45242 —
University Hospitals of Cleveland Cleveland Ohio 44106 —
Dayton Oncology & Hematology Kettering Ohio 45409 —
Toledo Clinic Cancer Center Toledo Ohio 43623 —
Oregon Health and Science University Portland Oregon 97239 —
Gettysburg Cancer Center Gettysburg Pennsylvania 17325 —
Pinnacle Health Cancer Institute Harrisburg Pennsylvania 17109 —
Abington Hematology Oncology Associates Willow Grove Pennsylvania 19090 —
Lankenau Medical Center Wynnewood Pennsylvania 19096 —
Charleston Oncology Charleston South Carolina 29414 —
MUSC Hollings Cancer Center Charleston South Carolina 29425 —
West Cancer Center Germantown Tennessee 38138 —
Brig Center For Cancer Care And Survivorship Knoxville Tennessee 37909 —
Texas Oncology - Central Austin Cancer Center Austin Texas 78731 —
Austin Cancer Centers Austin Texas 78759 —
Elligo Health Research Austin Texas 78759 —
Texas Oncology-Beaumont Beaumont Texas 77702 —
Texas Oncology-Methodist Dallas Cancer Center Dallas Texas 75203 —
Texas Oncology-Medical City Dallas Dallas Texas 75230 —
Texas Oncology-Presbyterian Cancer Center Dallas Dallas Texas 75231 —
Texas Oncology - Willowbrook Houston Texas 77070 —
Texas Oncology - McAllen McAllen Texas 78053 —
Texas Oncology-Mesquite Mesquite Texas 75150 —
Texas Oncology-Paris Paris Texas 76022 —
Texas Oncology-Plano West Plano Texas 75093 —
Texas Oncology-Plano East Plano Texas 80211 —
Cancer Therapy and Research Center at UTHSCSA San Antonio Texas 78229 —
Renovatio Medical The Woodlands The Woodlands Texas 77380 —
Texas Oncology - The Woodlands, Gynecologic Oncology The Woodlands Texas 77380 —
USO Texas Oncology - Tyler Tyler Texas 75702 —
Utah Cancer Specialists Salt Lake City Utah 84124 —
University of Virginia Cancer Center Charlottesville Virginia 22908 —
Inova Schar Cancer Institute Fairfax Virginia 22031 —
Fort Belvoir Community Hospital Fort Belvoir Virginia 22060 —
Benaroya Research Institute at Virginia Mason Seattle Washington 98101 —
University of Wisconsin Carbone Cancer Center Madison Wisconsin 53705 —
Colombia St. Mary's Medical Oncology Milwaukee Wisconsin 53211 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 140 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03778931, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 15, 2025 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03778931 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →